Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Cardiovascular diseases (CVDs) are a major burden on the healthcare system: indeed, over two million new cases are diagnosed every year worldwide. Unfortunately, important drawbacks for the treatment of these patients derive from our current inability to stop the structural alterations that lead to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Death Dis
Autori principali: Milan, Marika, Pace, Valentina, Maiullari, Fabio, Chirivì, Maila, Baci, Denisa, Maiullari, Silvia, Madaro, Luca, Maccari, Sonia, Stati, Tonino, Marano, Giuseppe, Frati, Giacomo, Puri, Pier Lorenzo, De Falco, Elena, Bearzi, Claudia, Rizzi, Roberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://ncbi.nlm.nih.gov/pubmed/29371598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0174-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi